CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
2.096
-0.024 (-1.12%)
Sep 11, 2026, 9:45 AM EDT - Market open

CalciMedica Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-19.63-23.12-24.2-21.88-14.19-21.54
Net Income
-21.24-29.56-13.7-34.36-9.14-23.5
Earnings Per Share
-6.65-9.85-6.09-38.29-555.78-43.26
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
18.6213.0218.6711.241.334.76
Total Debt
9.29.7---0.2
Net Cash (Debt)
9.423.3218.6711.241.334.57
Net Cash Growth
-0.42%-82.24%66.12%746.87%-70.94%-7.35%
Net Cash Per Share
2.951.108.3012.5280.678.41

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.11-21.18-21.15-25.73-11.76-20.51
Capital Expenditures
-0.01-0.03-0.01-0.08-0-0.21
Free Cash Flow
-19.12-21.21-21.15-25.81-11.76-20.72
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.